Market By Application, Route Of Administration, End-user And Region | Forecast 2019-2028
The detailed analysis by Triton Market Research on the global clinical nutrition market shows that, in terms of revenue, the industry is estimated to grow at a CAGR of 5.27% during the forecasting years 2019-2028. Besides, the market that was valued at $30.60 billion in 2019 will generate a revenue of $48.58 billion by the year 2028.
Clinical nutrition consists of pharmaceutical products that are utilized to keep a patient fit. It is used in order to improve the metabolic system by incorporating adequate supplements such as vitamins, minerals, proteins and others. Also, patients who are at risk for higher mortality due to the COVID-19 infection, polymorbid individuals and older adults, should be checked for a nutritional deficit.
Report scope can be customized per your requirements. Request For Customization
Clinical nutrition products are specialized in pharmaceutical supplements. They are designed for those patients that fail to develop required nutritional requirement naturally in their bodies on account of a disorder, disease or a medical condition. These supplements not only help them to enhance their body mechanism but also achieve an adequate nutritional intake, which they fail to get from normal diets, thereby increasing malnourishment chances.
The purpose of the study is to get an outline of the clinical nutrition market in terms of numerous factors. Within this report, the market definition and the key insights regarding the industry have been discussed. Also, Porter's five forces model, impact of COVID-19 on the clinical nutrition market, vendor scorecard and market attractiveness index have been studied in detail.
The increase in the number of people suffering from chronic health diseases and the surging number of malnutrition victims are driving the clinical nutrition market growth. However, the industry is facing market restraints like difficulties related to the enteral feeding and lack of awareness regarding clinical nutrition, which is obstructing the industry growth. Key opportunities like the growing prevalence of the aging population and rising usages of clinical nutrition in the developing countries can be leveraged by the industry to reach the projected growth. However, stringent regulatory framework and false perceptions associated with malnutrition are some of the challenges faced by this market.
Geographies covered in the global clinical nutrition market are:
• North America: United States and Canada
• Asia-Pacific: Japan, China, India, ASEAN countries, South Korea, Australia & New Zealand and Rest of Asia-Pacific
• Europe: United Kingdom, Germany, Italy, Russia, Spain, France and Rest of Europe
• Latin America: Mexico, Brazil and Rest of Latin America
• Middle East and Africa: Turkey, Saudi Arabia, South Africa, United Arab Emirates and Rest of Middle East & Africa
The clinical nutrition market has been segmented as follows:
• By Application
O Gastrointestinal disorders
O Cancer
O Metabolic disorders
O Neurological diseases
O Other applications
• By Route of Administration
O Oral
O Enteral
O Parenteral
• By End-user
O Geriatric
O Pediatric
O Adults
The key players engaged in the clinical nutrition market are Sichuan Kelun Pharmaceutical Co Ltd, Baxter International Inc, Avadel Pharmaceuticals, Lonza Inc, Reckitt Benckiser Group Plc, Danone, American Regent Inc, Sanofi SA, Exela Pharma Sciences, Abbott Laboratories, Meiji Holdings Co Ltd, Otsuka Holdings Co Ltd, Nestle Health Science, B Braun, BASF SE and Grifols SA. The strategic analysis for each of these companies has been covered in detail. The clinical nutrition market by company profiles helps to dive into the information about the key market players in this industry and how much hold they have on the market.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. GLOBAL CLINICAL NUTRITION MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. PORTER’S FIVE FORCES MODEL
2.2.1. THREAT OF NEW ENTRANTS
2.2.2. THREAT OF SUBSTITUTE PRODUCTS
2.2.3. BARGAINING POWER OF BUYERS
2.2.4. BARGAINING POWER OF SUPPLIERS
2.2.5. COMPETITIVE RIVALRY
2.3. IMPACT OF COVID-19 ON CLINICAL NUTRITION MARKET
2.4. MARKET ATTRACTIVENESS INDEX
2.5. VENDOR SCORECARD
2.6. KEY INSIGHTS
2.7. MARKET DRIVERS
2.7.1. INCREASING NUMBER OF PEOPLE SUFFERING FROM CHRONIC HEALTH DISEASES
2.7.2. SURGING NUMBER OF MALNUTRITION VICTIMS
2.8. MARKET RESTRAINTS
2.8.1. DIFFICULTIES RELATED TO ENTERAL FEEDING
2.8.2. LACK OF AWARENESS REGARDING CLINICAL NUTRITION
2.9. MARKET OPPORTUNITIES
2.9.1. GROWING AGING POPULATION
2.9.2. RISING USAGES OF CLINICAL NUTRITION IN DEVELOPING COUNTRIES
2.10. MARKET CHALLENGES
2.10.1. STRINGENT REGULATORY FRAMEWORK
2.10.2. FALSE PERCEPTIONS ASSOCIATED WITH MALNUTRITION
3. CLINICAL NUTRITION MARKET OUTLOOK - BY APPLICATION
3.1. CANCER
3.2. NEUROLOGICAL DISEASES
3.3. GASTROINTESTINAL DISORDERS
3.4. METABOLIC DISORDERS
3.5. OTHER APPLICATIONS
4. CLINICAL NUTRITION MARKET OUTLOOK - BY ROUTE OF ADMINISTRATION
4.1. ORAL
4.2. ENTERAL
4.3. PARENTERAL
5. CLINICAL NUTRITION MARKET OUTLOOK - BY END-USER
5.1. PEDIATRIC
5.2. GERIATRIC
5.3. ADULTS
6. CLINICAL NUTRITION MARKET – REGIONAL OUTLOOK
6.1. NORTH AMERICA
6.1.1. MARKET BY ROUTE OF ADMINISTRATION
6.1.2. MARKET BY APPLICATION
6.1.3. MARKET BY END-USER
6.1.4. COUNTRY ANALYSIS
6.1.4.1. UNITED STATES
6.1.4.2. CANADA
6.2. EUROPE
6.2.1. MARKET BY ROUTE OF ADMINISTRATION
6.2.2. MARKET BY APPLICATION
6.2.3. MARKET BY END-USER
6.2.4. COUNTRY ANALYSIS
6.2.4.1. GERMANY
6.2.4.2. FRANCE
6.2.4.3. UNITED KINGDOM
6.2.4.4. ITALY
6.2.4.5. RUSSIA
6.2.4.6. SPAIN
6.2.4.7. REST OF EUROPE
6.3. ASIA-PACIFIC
6.3.1. MARKET BY ROUTE OF ADMINISTRATION
6.3.2. MARKET BY APPLICATION
6.3.3. MARKET BY END-USER
6.3.4. COUNTRY ANALYSIS
6.3.4.1. JAPAN
6.3.4.2. CHINA
6.3.4.3. INDIA
6.3.4.4. AUSTRALIA & NEW ZEALAND
6.3.4.5. SOUTH KOREA
6.3.4.6. ASEAN COUNTRIES
6.3.4.7. REST OF ASIA-PACIFIC
6.4. LATIN AMERICA
6.4.1. MARKET BY ROUTE OF ADMINISTRATION
6.4.2. MARKET BY APPLICATION
6.4.3. MARKET BY END-USER
6.4.4. COUNTRY ANALYSIS
6.4.4.1. BRAZIL
6.4.4.2. MEXICO
6.4.4.3. REST OF LATIN AMERICA
6.5. MIDDLE EAST AND AFRICA
6.5.1. MARKET BY ROUTE OF ADMINISTRATION
6.5.2. MARKET BY APPLICATION
6.5.3. MARKET BY END-USER
6.5.4. COUNTRY ANALYSIS
6.5.4.1. SAUDI ARABIA
6.5.4.2. TURKEY
6.5.4.3. UNITED ARAB EMIRATES
6.5.4.4. SOUTH AFRICA
6.5.4.5. REST OF MIDDLE EAST & AFRICA
7. COMPANY PROFILES
7.1. NESTLE HEALTH SCIENCE
7.2. BASF SE
7.3. AVADEL PHARMACEUTICALS
7.4. MEIJI HOLDINGS CO LTD
7.5. BAXTER INTERNATIONAL INC
7.6. RECKITT BENCKISER GROUP PLC
7.7. B BRAUN
7.8. SANOFI SA
7.9. AMERICAN REGENT INC
7.10. OTSUKA HOLDINGS CO LTD
7.11. ABBOTT LABORATORIES
7.12. SICHUAN KELUN PHARMACEUTICAL CO LTD
7.13. LONZA INC
7.14. DANONE
7.15. GRIFOLS SA
7.16. EXELA PHARMA SCIENCES
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.1.1. OBJECTIVES OF STUDY
8.1.2. SCOPE OF STUDY
8.2. SOURCES OF DATA
8.2.1. PRIMARY DATA SOURCES
8.2.2. SECONDARY DATA SOURCES
8.3. RESEARCH METHODOLOGY
8.3.1. EVALUATION OF PROPOSED MARKET
8.3.2. IDENTIFICATION OF DATA SOURCES
8.3.3. ASSESSMENT OF MARKET DETERMINANTS
8.3.4. DATA COLLECTION
8.3.5. DATA VALIDATION & ANALYSIS
TABLE 1 GLOBAL CLINICAL NUTRITION MARKET, BY REGION, 2019-2028 (IN $ MILLION)
TABLE 2 VENDOR SCORECARD
TABLE 3 NUMBER OF AGING POPULATION 2019 AND 2050 (MILLION)
TABLE 4 GLOBAL CLINICAL NUTRITION MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE 5 GLOBAL CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (IN $ MILLION)
TABLE 6 GLOBAL CLINICAL NUTRITION MARKET, BY END-USER, 2019-2028 (IN $ MILLION)
TABLE 7 GLOBAL CLINICAL NUTRITION MARKET, BY REGION, 2019-2028 (IN $ MILLION)
TABLE 8 NORTH AMERICA CLINICAL NUTRITION MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 9 NORTH AMERICA CLINICAL NUTRITION MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE 10 NORTH AMERICA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (IN $ MILLION)
TABLE 11 NORTH AMERICA CLINICAL NUTRITION MARKET, BY END-USER, 2019-2028 (IN $ MILLION)
TABLE 12 EUROPE CLINICAL NUTRITION MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 13 EUROPE CLINICAL NUTRITION MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE 14 EUROPE CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (IN $ MILLION)
TABLE 15 EUROPE CLINICAL NUTRITION MARKET, BY END-USER, 2019-2028 (IN $ MILLION)
TABLE 16 ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 17 ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE 18 ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (IN $ MILLION)
TABLE 19 ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY END-USER, 2019-2028 (IN $ MILLION)
TABLE 20 LATIN AMERICA CLINICAL NUTRITION MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 21 LATIN AMERICA CLINICAL NUTRITION MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE 22 LATIN AMERICA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (IN $ MILLION)
TABLE 23 LATIN AMERICA CLINICAL NUTRITION MARKET, BY END-USER, 2019-2028 (IN $ MILLION)
TABLE 24 MIDDLE EAST & AFRICA CLINICAL NUTRITION MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 25 MIDDLE EAST AND AFRICA CLINICAL NUTRITION MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE 26 MIDDLE EAST AND AFRICA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (IN $ MILLION)
TABLE 27 MIDDLE EAST AND AFRICA CLINICAL NUTRITION MARKET, BY END-USER, 2019-2028 (IN $ MILLION)
FIGURE 1 GLOBAL CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 2 DIFFICULTIES ASSOCIATED WITH ENTERAL FEEDING
FIGURE 3 GLOBAL CLINICAL NUTRITION MARKET, BY CANCER, 2019-2028 (IN $ MILLION)
FIGURE 4 GLOBAL CLINICAL NUTRITION MARKET, BY NEUROLOGICAL DISEASES, 2019-2028 (IN $ MILLION)
FIGURE 5 GLOBAL CLINICAL NUTRITION MARKET, BY GASTROINTESTINAL DISORDERS, 2019-2028 (IN $ MILLION)
FIGURE 6 GLOBAL CLINICAL NUTRITION MARKET, BY METABOLIC DISORDERS, 2019-2028 (IN $ MILLION)
FIGURE 7 GLOBAL CLINICAL NUTRITION MARKET, BY OTHER APPLICATIONS, 2019-2028 (IN $ MILLION)
FIGURE 8 GLOBAL CLINICAL NUTRITION MARKET, BY ORAL, 2019-2028 (IN $ MILLION)
FIGURE 9 GLOBAL CLINICAL NUTRITION MARKET, BY ENTERAL, 2019-2028 (IN $ MILLION)
FIGURE 10 GLOBAL CLINICAL NUTRITION MARKET, BY PARENTERAL, 2019-2028 (IN $ MILLION)
FIGURE 11 GLOBAL CLINICAL NUTRITION MARKET, BY PEDIATRIC, 2019-2028 (IN $ MILLION)
FIGURE 12 GLOBAL CLINICAL NUTRITION MARKET, BY GERIATRIC, 2019-2028 (IN $ MILLION)
FIGURE 13 GLOBAL CLINICAL NUTRITION MARKET, BY ADULTS, 2019-2028 (IN $ MILLION)
FIGURE 14 UNITED STATES CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 15 CANADA CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 16 GERMANY CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 17 FRANCE CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 18 UNITED KINGDOM CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 19 ITALY CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 20 RUSSIA CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 21 SPAIN CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 22 REST OF EUROPE CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 23 JAPAN CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 24 CHINA CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 25 INDIA CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 26 AUSTRALIA & NEW ZEALAND CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 27 SOUTH KOREA CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 28 ASEAN COUNTRIES CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 29 REST OF ASIA-PACIFIC CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 30 BRAZIL CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 31 MEXICO CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 32 REST OF LATIN AMERICA CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 33 SAUDI ARABIA CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 34 TURKEY CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 35 UNITED ARAB EMIRATES CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 36 SOUTH AFRICA CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 37 REST OF MIDDLE EAST & AFRICA CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)